Recognizing Symptoms and Warning Signs of HCC
At a Glance
Hepatocellular carcinoma (HCC) is often 'silent' in early stages due to the liver's large reserve capacity. As the tumor grows, symptoms may include unexplained weight loss, fatigue, right-sided abdominal pain, jaundice, and abdominal swelling.
One of the most challenging aspects of Hepatocellular Carcinoma (HCC) is that it is often a “silent” disease in its early stages. Because the liver is a large organ with significant reserve capacity, a tumor can often grow without causing any noticeable physical changes [1]. Recognizing the symptoms requires understanding both the direct effects of the cancer and the signs that your liver’s overall function may be declining.
Why HCC is Often Asymptomatic
Most patients do not feel “sick” when HCC first develops. This is because the tumor is typically small and hasn’t yet interfered with the liver’s ability to perform its vital tasks, such as filtering blood or producing proteins [1].
For many, the first signs of HCC are discovered not through symptoms, but through regular surveillance (screening) using blood tests and imaging [2]. When symptoms do appear, they often signal that the tumor has grown significantly or that the underlying liver disease has worsened.
Common Signs and Symptoms
As HCC progresses, it may cause a variety of symptoms. Some are “constitutional,” meaning they affect the whole body, while others are specific to the liver area.
Early or Vague Signs
- Unexplained Weight Loss: Losing weight without trying is a hallmark sign of many cancers, including HCC.
- Loss of Appetite: Feeling full after eating only a small amount of food.
- Vague Abdominal Discomfort: A dull ache or “fullness” in the upper right side of the belly, just below the ribs.
- Fatigue: Persistent tiredness that doesn’t improve with rest.
Signs of Tumor Growth or Advanced Disease
- Jaundice: A yellowing of the skin and the whites of the eyes caused by a buildup of bilirubin (a yellow compound produced when old red blood cells break down) [3].
- Abdominal Swelling (Ascites): A buildup of fluid in the belly that can make it feel tight or look bloated [3].
- Pain in the Right Shoulder: Occasionally, a liver tumor can irritate the diaphragm, causing “referred pain” that is felt in the right shoulder blade.
- Easy Bruising or Bleeding: The liver produces the proteins needed for blood clotting; if it is compromised, you may notice more frequent bruises or nosebleeds.
Distinguishing Tumor Signs from Liver Failure
It is important to understand the difference between symptoms caused by the tumor itself and those caused by hepatic decompensation (the liver losing its ability to function due to underlying cirrhosis) [4][5].
- Tumor-Specific: Sharp pain in the liver area, a physical lump felt under the ribs, or sudden weight loss [6].
- Decompensation-Specific: Confusion or “brain fog” (hepatic encephalopathy), severe swelling in the legs (edema), or vomiting blood due to enlarged veins in the esophagus (varices) [7][3].
Conditions That Can Mimic HCC
Because the symptoms of HCC are often non-specific, they can be easily confused with other conditions. Your doctor will use specialized imaging to tell them apart.
- Cirrhosis: General liver scarring can cause the same fatigue, jaundice, and swelling as HCC [8].
- Gallstones: These can cause sharp pain in the upper right abdomen and jaundice, mimicking a tumor that blocks a bile duct.
- Benign Liver Lesions: Non-cancerous growths, such as focal nodular hyperplasia (FNH) or hemangiomas (clusters of blood vessels), can look like HCC on basic scans [9][10].
- Regenerative Nodules: In a scarred liver, the liver tries to heal itself by forming nodules. These are common in cirrhosis and can be difficult to distinguish from early cancer without high-quality MRI or CT scans [9].
When to Seek Medical Attention
If you have a known history of liver disease (such as Hepatitis B, Hepatitis C, or fatty liver), any new or worsening symptoms should be reported to your care team immediately. Monitoring for sarcopenia (loss of muscle mass) is also vital, as this can be a subtle but important marker of disease progression [7].
Common questions in this guide
Why doesn't liver cancer cause symptoms right away?
What are the early warning signs of HCC?
How can I tell the difference between liver cancer symptoms and general liver failure?
What non-cancerous conditions mimic HCC symptoms?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my current fatigue or abdominal discomfort related to the tumor itself or my underlying liver health?
- 2.What specific labs, such as my bilirubin levels, should I be monitoring for signs of liver decompensation?
- 3.If I notice new swelling in my legs or abdomen, who on my care team should I contact first?
- 4.Could my symptoms be explained by a non-cancerous condition, like gallstones or a benign liver nodule?
- 5.What are the 'red flag' symptoms that should prompt an immediate visit to the emergency room?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
Consensus on the secondary prevention of primary liver cancer.
Nan Y, Xu X, Gao Y, et al.
Hepatology international 2021; (15(6)):1289-1300 doi:10.1007/s12072-021-10259-7.
PMID: 34846705 - 2
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Impacts Long-Term Outcomes After Curative-Intent Surgery for Hepatocellular Carcinoma.
Uluk D, Pein J, Herda S, et al.
Alimentary pharmacology & therapeutics 2025; (61(8)):1318-1332 doi:10.1111/apt.70002.
PMID: 39964081 - 3
Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.
Liu B, Teng F, Fu H, et al.
BMC gastroenterology 2015; (15()):138 doi:10.1186/s12876-015-0364-5.
PMID: 26472203 - 4
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma.
Cabibbo G, Celsa C, Bhoori S, et al.
Journal of hepatology 2025; (83(6)):1443-1451 doi:10.1016/j.jhep.2025.07.020.
PMID: 40759204 - 5
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.
Piñero F, Anders M, Bermudez C, et al.
Liver international : official journal of the International Association for the Study of the Liver 2025; (45(5)):e70092 doi:10.1111/liv.70092.
PMID: 40208044 - 6
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B.
Lee HW, Yip TC, Tse YK, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021; (19(9)):1950-1958.e7 doi:10.1016/j.cgh.2020.08.064.
PMID: 32889148 - 7
Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients.
Badran H, Elsabaawy MM, Ragab A, et al.
Asian Pacific journal of cancer prevention : APJCP 2020; (21(11)):3285-3290 doi:10.31557/APJCP.2020.21.11.3285.
PMID: 33247686 - 8
Model of End-Stage Liver Disease-alpha-fetoprotein-tumor burden (MELD-AFP-TBS) score to stratify prognosis after liver resection for hepatocellular carcinoma.
Kawashima J, Akabane M, Khalil M, et al.
Surgery 2025; (183()):109388 doi:10.1016/j.surg.2025.109388.
PMID: 40311416 - 9
Prevalence of benign focal liver lesions and non-hepatocellular carcinoma malignant lesions in liver cirrhosis.
Möller K, Safai Zadeh E, Görg C, et al.
Zeitschrift fur Gastroenterologie 2023; (61(5)):526-535 doi:10.1055/a-1890-5818.
PMID: 36413993 - 10
Benign Hepatic Nodules Mimicking Hepatocellular Carcinoma in the Setting of Fontan-associated Liver Disease: A Case Report.
Çolaklar A, Lehnert SJ, Tirkes T
Euroasian journal of hepato-gastroenterology 2020; (10(1)):42-44 doi:10.5005/jp-journals-10018-1315.
PMID: 32742972
This page provides educational information about HCC symptoms and warning signs. It is not a substitute for professional medical advice. Always contact your healthcare provider if you experience new, worsening, or concerning physical changes.
Get notified when new evidence is published on Adult hepatocellular carcinoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.